Stock listing

NASDAQ:VRTX Vertex Pharmaceuticals Incorporated Stock

Home listing (NASDAQ) of Vertex Pharmaceuticals Incorporated

Follow Vertex Pharmaceuticals Incorporated into a list and get an email when it puts out news.

Share price · NASDAQ:VRTX

$499.74 USD -9.01 (-1.8%)

Close on Oct 16, 2026

Vertex Pharmaceuticals Incorporated logo
Ticker
NASDAQ:VRTX
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Vertex Pharmaceuticals (NASDAQ:VRTX) Q2 2026 Earnings Call

    Mon, Aug 03, 2026 · 4:30 PM ET

    Watch Transcript

  • Vertex Pharmaceuticals (NASDAQ:VRTX) Q1 2026 Earnings Call

    Mon, May 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Vertex Pharmaceuticals (NASDAQ:VRTX) Q4 2025 Earnings Call

    Thu, Feb 12, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference

Oct 9, 2026

Vertex to Announce Third Quarter 2026 Financial Results November 2nd

Oct 7, 2026

Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

Sep 22, 2026

Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain

Sep 15, 2026

Vertex to Present at the Goldman Sachs Communacopia + Technology Conference

Sep 3, 2026

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

Sep 1, 2026

Quarterly Report for Quarter Ending JUNE 30, 2026 (Form 10-Q)

Aug 4, 2026

Vertex Reports Second Quarter 2026 Financial Results

Aug 3, 2026

Vertex to Announce Second Quarter 2026 Financial Results on Monday, August 3, 2026

Jul 14, 2026

Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Orphan Drug Markets

Jul 9, 2026

All Vertex Pharmaceuticals Incorporated news

Decks

Vertex Pharmaceuticals Incorporated on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
48 in the last 12 months · 276 in all · newest Oct 9, 2026 · oldest 2019
Calls
31 calls with a replay · 31 with a transcript · latest Aug 3, 2026
Decks
18 decks · latest Aug 3, 2026

Where Vertex Pharmaceuticals Incorporated is listed

ListingExchangeCountryCurrency
NASDAQ:VRTX · Home listing · This pageNASDAQUnited StatesUSD
Xetra:VX1XetraGermanyEUR
gettex:VX1gettexGermanyEUR
BCBA:VRTXBCBAArgentinaARS
Tradegate:VX1TradegateGermanyEUR
LS Exchange:882807LS ExchangeGermanyEUR
BMV:VRTXBMVMexicoMXN
B3:VRTX34B3BrazilBRL
Lang & Schwarz:882807Lang & SchwarzGermanyEUR
LSE:0QZULSEUnited KingdomUSD
Frankfurt:VX1FrankfurtGermanyEUR
EUROTLX:4VRTXEUROTLXItalyEUR
BCBA:VRTXDBCBAArgentinaUSD
Milan:1VRTXMilanItalyEUR
VIE:VRTXViennaAustriaEUR
BIVA:VRTXBIVAMexicoMXN
BOATS:VRTXBOATSUnited StatesUSD
Stuttgart:VX1StuttgartGermanyEUR
Dusseldorf:VX1DusseldorfGermanyEUR
Hanover:VX1HanoverGermanyEUR
Munich:VX1MunichGermanyEUR
BX Swiss:VX1BX SwissSwitzerlandCHF
Aquis:VX1DAquisUnited KingdomEUR
BCBA:VRTXCBCBAArgentinaUSD
Hamburg:VX1HamburgGermanyEUR
Aquis:VX1DAquisUnited KingdomEUR
Turquoise:VRTXNTurquoiseUnited KingdomUSD
BCBA:VRTX.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Vertex Pharmaceuticals Incorporated.